North Shore University Hospital

Feinstein Institutes, Northwell Use Ultrasound to Treat Brain Tumors in Novel Clinical Trial

Retrieved on: 
Thursday, January 12, 2023
Oncology, Health, Clinical Trials, Research, Pharmaceutical, Science, Brain, Israeli Navy, Feinstein, Feinstein Institute for Medical Research, Credit, Neoplasm, Medical research, Molecular medicine, Medicine, Safety, North Shore University Hospital, Glioblastoma, Patient, Radiation, Neurology, Clinical trial, Northwell Health, Multimedia, SDT, Alpheus, Medical imaging, Oligodendroglioma, MD, Neurosurgery

View the full release here: https://www.businesswire.com/news/home/20230112005272/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230112005272/en/
    Yehuda Haber (left) speaks with Dr. Michael Schulder about the Alpheus Medical ultrasound clinical trial.
  • (Credit: Feinstein Institutes)
    There are few therapeutic options to treat these recurrences for many patients diagnosed with high-grade gliomas, including glioblastoma.
  • This multi-site clinical trial looks to study the safety and optimal dosage of an investigational novel sonodynamic therapy (SDT) platform, which targets solid body cancers through ultrasound.
  • Schulder’s clinical research on brain tumors produces essential new knowledge to guide future therapeutic strategies.”
    Alpheus Medical is the sponsor of the trial.

Provention Bio Announces Appointment of Rita Jain, M.D., to Board of Directors

Retrieved on: 
Thursday, January 5, 2023
AbbVie, Akebia, Nephrology, Abbott, Pain, Biotechnology, Shire (pharmaceutical company), Therapy, Drug development, Divisional Railway Hospital, Golden Rock, Pharmacia & Upjohn, North Shore University Hospital, Inflammation, Health, The Stony Brook School, BANK, Abbott Laboratories, Amgen, Acquisition, G.D. Searle, LLC, Arthritis, State university system, FDA, Laboratory, Pharmacia, Senior, RED, Metabolism, Pharmaceutical industry, Pfizer, Medicine, Biology

RED BANK, N.J., Jan. 5, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of Rita Jain, M.D., to the Company's Board of Directors.

Key Points: 
  • RED BANK, N.J., Jan. 5, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the appointment of Rita Jain, M.D., to the Company's Board of Directors.
  • "Rita brings extensive drug development experience to Provention Bio across a wide range of therapeutic areas including autoimmune and metabolic diseases," said Wayne Pisano, Chairman of the Board of Provention Bio.
  • Dr. Jain, a board-certified rheumatologist, currently serves as a member of the supervisory board of AM Pharma and previously served on the Board of Directors of ChemoCentryx, Inc. until its acquisition by Amgen.
  • Earlier in her career, Dr. Jain served as a faculty member at North Shore University Hospital in New York.

Feinstein Institutes, Northwell electrophysiologist successfully implant first modular cardiac rhythm management system in novel clinical trial

Retrieved on: 
Friday, October 21, 2022
Health, Medical Devices, Surgery, Health Technology, Clinical Trials, Cardiology, Biotechnology, Physician, LinkedIn, Communication, Risk, Medicine, CRM, Population, Science, Arrest, Medical research, MPS, Patient, Research, Multimedia, Feinstein Institute for Medical Research, Mental health, Electrophysiology, EMPOWER, Cancer, Emergency department, Molecular medicine, Subcutaneous Implantable Defibrillator (S-ICD), Laurence, Autoimmunity, Genetics, Clinical trial, Shock, Nursing, Cardiac arrest, Northwell Health, ATP, North Shore University Hospital, Heart, Death, Perspiration, Credit, Coma, Medical device, Boston Scientific, MD

Like a paramedic in your chest, a team of Northwell Health clinicians, electrophysiologists and clinical trial investigators at The Feinstein Institutes for Medical Research successfully implanted a modular cardiac rhythm management (CRM) system in the first patient to be enrolled in the Boston Scientific MODULAR ATP clinical trial.

Key Points: 
  • Like a paramedic in your chest, a team of Northwell Health clinicians, electrophysiologists and clinical trial investigators at The Feinstein Institutes for Medical Research successfully implanted a modular cardiac rhythm management (CRM) system in the first patient to be enrolled in the Boston Scientific MODULAR ATP clinical trial.
  • View the full release here: https://www.businesswire.com/news/home/20221021005348/en/
    Laurence M. Epstein, MD (center right) implanted the first patient in Boston Scientifics MODULAR ATP clinical trial at North Shore University Hospital.
  • The trial will also investigate the system and procedure-related complication-free rate of the EMPOWER MPS.
  • The MODULAR ATP trial will enroll up to 60 centers in the U.S., Canada and Europe up to 300 patients.

Northwell Health surpasses $1 billion goal in its first system-wide fundraising campaign

Retrieved on: 
Thursday, September 22, 2022
Managed Care, Other Health, General Health, Philanthropy, Oncology, Mental Health, Hospitals, Fund Raising, Health Insurance, Foundation, Clinical Trials, Other Philanthropy, Health, Neuroscience, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hospital, Goal, Impossible, Foundation, Health equity, Patient, Physician, Leadership, Helen, Staten Island University Hospital, Research, Lenox Hill Hospital, MPH, Child, Nursing, Teaching hospital, Katz, Cohen, New Yorkers, Clifford, North Shore University Hospital, MPP, Doctor of Philosophy, Feinstein Institute for Medical Research, Medicine, Glen Cove Hospital, Health, Institute of Liver and Biliary Sciences, Woman, Autoimmunity, COVID-19, Adolescence, Faculty, Investor, Program, Cancer, Medical research, Intensive care unit, Multimedia, Education, Pharmaceutical industry, Management, Northwell Health, JD, MD

Northwell Health , New York States largest non-profit healthcare provider and private employer, today announced it surpassed the $1 billion goal in its first system-wide comprehensive fundraising campaign.

Key Points: 
  • Northwell Health , New York States largest non-profit healthcare provider and private employer, today announced it surpassed the $1 billion goal in its first system-wide comprehensive fundraising campaign.
  • Credit Northwell Health
    Outpacing the Impossible: The Northwell Campaign supports Northwell's promise to the people and communities it serves.
  • We set a goal to raise $1 billion and weve done that, said Northwell Health President and CEO Michael Dowling .
  • Our 80,000 employees 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners are working to change health care for the better.

Stratus appoints Dr. Selim Benbadis and Dr. Omotola Hope to its Medical Advisory Board

Retrieved on: 
Thursday, August 25, 2022
Machine learning, Yale School of Medicine, Patient, University, North Shore University Hospital, Technology, Program, Research, Memorial Hermann–Texas Medical Center, Seizure, Solution, Yale New Haven Hospital, Hope, Cleveland, Internal medicine, EEG, Physician, MAB, Diagnosis, McGovern Medical School, Neurology, Education, Faculty, R&D, MD, Stratus, Database, Population, Efficiency, Houston Methodist Sugar Land Hospital, Knowledge, Epilepsy, Cleveland Clinic, University of South Florida Tampa Library, Health, Pharmaceutical industry, Medicine, DALLAS

DALLAS, Aug. 25, 2022 /PRNewswire-PRWeb/ -- Stratus announced the appointment of Selim Benbadis, MD, and Omotola Hope, MD, to the company's Medical Advisory Board. Formed in 2018, Stratus' Medical Advisory Board (MAB) provides critical guidance and insight to the company as it develops new neurodiagnostic services and solutions. The addition of Dr. Benbadis and Dr.Hope broadens the diversity of Stratus' MAB and supports the company's commitment to serving a diverse patient population and expanding patient care and access.

Key Points: 
  • The appointment of Selim Benbadis, M.D., and Omotola Hope, M.D., will help support Stratus' commitment to serving a diverse patient population.
  • DALLAS, Aug. 25, 2022 /PRNewswire-PRWeb/ -- Stratus announced the appointment of Selim Benbadis, MD, and Omotola Hope, MD, to the company's Medical Advisory Board.
  • Formed in 2018, Stratus' Medical Advisory Board (MAB) provides critical guidance and insight to the company as it develops new neurodiagnostic services and solutions.
  • Benbadis graduated from medical school at the University of Nice (Nice, France), where he completed a residency in family medicine.

Northwell Hospitals Earn High Marks From CMS

Retrieved on: 
Thursday, July 28, 2022
General Health, Other Health, Hospitals, Health, Managed Care, Glen Cove Hospital, Northwell Health, United States Department of Health and Human Services, Quality, Mortality, Physician, Feinstein Institute for Medical Research, Twitter, Instagram, 1968 Australian One and a Half Litre Championship, Hospital, Health, CEO, Northern Westchester Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Medical Center, CMS, North Shore University Hospital, Safety, Nursing, Multimedia, DRS, Star, Staten Island University Hospital, Human services, Teaching hospital, Credit, Lenox Hill Hospital, MD, LinkedIn, Medical research, Department, Huntington Hospital, Vaccination, Center, Medicare, Centers for Medicare & Medicaid Services, Medicine, Hotel, Facebook, Peconic Bay

Seven Northwell Health hospitals have received four-star or better ratings from the Centers for Medicare and Medicaid Services (CMS) as part of its 2022 Five-Star Quality Rating System, which were announced Wednesday.

Key Points: 
  • Seven Northwell Health hospitals have received four-star or better ratings from the Centers for Medicare and Medicaid Services (CMS) as part of its 2022 Five-Star Quality Rating System, which were announced Wednesday.
  • View the full release here: https://www.businesswire.com/news/home/20220728005814/en/
    Seven Northwell Health hospitals have received four-star or better ratings from CMS as part of its 2022 Five-Star Quality Rating list.
  • Northwell, New York States largest health system and private employer, saw 11 of the 12 hospitals evaluated either maintain or improve their CMS standing since 2021.
  • I see the amazing effort by Northwell Health team members every time I step inside one of our hospitals and those results are reflected in CMS latest ratings, said Michael Dowling , Northwells president and CEO.

Five Northwell hospitals earn top 50 specialty ratings by US News

Retrieved on: 
Tuesday, July 26, 2022
Nursing, Health, Hospitals, Surgery, Practice Management, Managed Care, Glen Cove Hospital, Northwell Health, Feinstein Institute for Medical Research, Physician, U.S. News & World Report, Lenox Hill, Twitter, Instagram, Hospital, Health, CEO, Long Island Jewish Medical Center, Ear, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Workforce, North Shore University Hospital, Journal of Neurology, Neurosurgery, and Psychiatry, Adult, U.S. News & World Report Best Hospitals Rankings, Multimedia, Obstetrics, Geriatrics, News, Cancer, Teaching hospital, Nursing, Lenox Hill Hospital, MD, Medical research, LinkedIn, Heart, Huntington Hospital, Gynaecology, Elective surgery, Nose, Medicine, Dentistry, Facebook

Five Northwell Health hospitals earned top 50 national rankings in 28 adult medical specialties eight of them top 20 specialties according to US News & World Reports 2022-23 Best Hospital rankings.

Key Points: 
  • Five Northwell Health hospitals earned top 50 national rankings in 28 adult medical specialties eight of them top 20 specialties according to US News & World Reports 2022-23 Best Hospital rankings.
  • Northwell Health has faced herculean challenges over these last two pandemic years and weve become stronger for it.
  • Northwell Health is New York States largest health care provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 12,000 affiliated physicians.
  • For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook , Twitter , Instagram and LinkedIn .

FDA Grants Alpheus Medical Orphan Drug and Fast Track Designations for Novel Sonodynamic Therapy for Brain Cancer

Retrieved on: 
Wednesday, July 13, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Disease, Clinical trial, Alpheus, Glioblastoma, Safety, National Brain Tumor Society, Teaching hospital, Northwell Health, Neurology, Brain, Communication, Multimedia, North Shore University Hospital, UCL Queen Square Institute of Neurology, American Cancer Society, Patient, CEO, MD, Food, Fast track (FDA), Fast Track, SDT, Glioma, FDA, Institute, Pharmaceutical industry, Medical imaging, Neurosurgery

OAKDALE, Minn., July 13, 2022  /PRNewswire/ -- Alpheus™ Medical, Inc, a privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid body cancers, today announced the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug and Fast Track Designations to Alpheus Medical's CV-01 delivery of sonodynamic therapy (SDT) as a potential treatment for patients with recurrent glioblastoma, the most common primary brain cancer, and other malignant gliomas. Northwell Health's North Shore University Hospital in Long Island, New York, is currently enrolling patients in the multi-center Phase 1 clinical trial. The First-in-Human trial will evaluate the safety, optimal dosage, and efficacy of Alpheus' SDT platform in patients with recurrent high-grade glioma.

Key Points: 
  • OAKDALE, Minn., July 13, 2022 /PRNewswire/ --Alpheus Medical, Inc, a privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid body cancers, today announced the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug and Fast Track Designations to Alpheus Medical's CV-01 delivery of sonodynamic therapy (SDT) as a potential treatment for patients with recurrent glioblastoma, the most common primary brain cancer, and other malignant gliomas.
  • "The FDA Fast Track and Orphan Drug Designations are significant milestones and highlight the importance of innovation within the field of brain cancer," stated Dr. Vijay Agarwal, CEO and founder of Alpheus Medical and a practicing brain tumor surgeon.
  • The Fast Track designation enables early and frequent communication between FDA and product sponsor throughout the development and review process.
  • Alpheus Medical, Inc, is a privately held company developing a novel sonodynamic therapy (SDT) platform targeting solid body cancers.

Northwell Health selects Vibe Health by eVideon to Accelerate Digital Transformation

Retrieved on: 
Tuesday, July 12, 2022
Technology, EMR, Goal, Trauma, SVP, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Nursing, North Shore University Hospital, LinkedIn, Medical research, Future, Partnership, Patient, CEO, Documentation, Instagram, Human, Physician, Feinstein Institute for Medical Research, Donald, Language, Fortune, Twitter, Hospital, Workforce, Medicine, Facebook

GRAND RAPIDS, Mich., July 12, 2022 /PRNewswire-PRWeb/ -- eVideon, a leader in interactive patient engagement and digital workflow solutions, announces a new partnership with Northwell Health, the largest healthcare provider and private employer in the state of New York. Recognized for the third year in a row as one of Fortune's 100 Best Companies to Work For®, Northwell Health is committed to leveraging innovation to raise the standard of care and elevate the experience for their patients, families, workforce, and communities.

Key Points: 
  • Through this partnership, Northwell will start using eVideon's Vibe Health platform at North Shore University Hospital in Q4 of this year.
  • "Creating an interactive future state that improves information access, simplifies clinical workflows, and personalizes the care experience is a priority at Northwell Health," said Sven Gierlinger, SVP and Chief Experience Officer at Northwell Health.
  • By partnering with eVideon, Northwell Health is giving patients, families, and clinicians a modern, tech-enabled experience that promotes continuous innovation and supports the goals and priorities of the health system.
  • Our 79,000 employees 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners are working to change health care for the better.

The Ricco Dental Group Embraces Latest Dental Technologies, Launches New Website

Retrieved on: 
Monday, July 11, 2022
American Dental Association, Health, Teaching hospital, Diabetes, Disease, State university system, The Stony Brook School, Postgraduate training in general dentistry, Degenerative disease, Align Technology, Mental health, Mouth, Academy, Breast implant, Dental care, Technology, Learning, Dentistry, Patient, Academy of General Dentistry, North Shore University Hospital, Osseointegration

PLAINVIEW, N.Y., July 11, 2022 /PRNewswire-PRWeb/ -- To provide patients with the most comfortable, and advanced dental care available, The Ricco Dental Group uses the latest dental technologies, aimed at creating a relaxing patient experience, even for those who are fearful of going to the dentist. The Ricco Dental Group is a full-service dental practice providing preventative, restorative, and cosmetic dental treatments in Plainview, NY.

Key Points: 
  • The Ricco Dental Group is a full-service dental practice providing preventative, restorative, and cosmetic dental treatments in Plainview, NY.
  • The Ricco Dental Group is a full-service dental practice providing preventative, restorative, and cosmetic dental treatments in Plainview, NY.
  • That's our goal at The Ricco Dental Group: to help patients to achieve and maintain good oral health, thereby contributing to overall health and wellness," Dr. Ricco said.
  • The Ricco Dental Group is located at 709 S Oyster Bay Rd, Plainview, NY 11803.